Baslam A, Aitbaba A, Hanchi A, Tazart Z, Aboufatima R, Soraa N
Int J Mol Sci. 2023; 24(10).
PMID: 37240429
PMC: 10219441.
DOI: 10.3390/ijms24109086.
Moore D, Turner J, Goodwin J, Fulton S, Singer L, Parrott A
Clin Dev Med. 2022; 188:169-182.
PMID: 35422536
PMC: 9007183.
Immanuel David C, Bhuvanesh N, Jayaraj H, Thamilselvan A, Parimala Devi D, Abiram A
ACS Omega. 2020; 5(6):3055-3072.
PMID: 32095729
PMC: 7033979.
DOI: 10.1021/acsomega.9b04294.
Salathe C, Blanc A, Tagan D
BMJ Case Rep. 2018; 2018.
PMID: 30158258
PMC: 6119400.
DOI: 10.1136/bcr-2018-224731.
Budzynska B, Wnorowski A, Kaszubska K, Biala G, Kruk-Slomka M, Kurzepa J
Front Behav Neurosci. 2018; 12:149.
PMID: 30116179
PMC: 6082960.
DOI: 10.3389/fnbeh.2018.00149.
Effects of Repeated Administration of 3,4-methylenedioxymethamphetamine (MDMA) on Avoidance Memory and Cell Density in Rats' Hippocampus.
Jahanshahi M, Haidari K, Mahaki-Zadeh S, Nikmahzar E, Babakordi F
Basic Clin Neurosci. 2014; 4(1):57-63.
PMID: 25337329
PMC: 4202557.
MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology.
Saez-Briones P, Hernandez A
Curr Neuropharmacol. 2014; 11(5):521-34.
PMID: 24403876
PMC: 3763760.
DOI: 10.2174/1570159X11311050007.
Substance of abuse and movement disorders: complex interactions and comorbidities.
Deik A, Saunders-Pullman R, San Luciano M
Curr Drug Abuse Rev. 2012; 5(3):243-53.
PMID: 23030352
PMC: 3966544.
DOI: 10.2174/1874473711205030243.
Dexmedetomidine to control agitation and delirium from toxic ingestions in adolescents.
Tobias J
J Pediatr Pharmacol Ther. 2012; 15(1):43-8.
PMID: 22477792
PMC: 3017407.
(±)-3,4-methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice.
Scheidweiler K, Ladenheim B, Barnes A, Cadet J, Huestis M
J Anal Toxicol. 2011; 35(7):470-80.
PMID: 21871156
PMC: 6684102.
DOI: 10.1093/anatox/35.7.470.
Geonotoxicity study of illegal drug MDMA and its nitroso derivative N-MDMA by micronucleus and chromosomal aberration tests using Chinese hamsger lung fibroblast cell line.
Yoshioka H, Shimizu H, Toyama Y, Miyakoshi Y, Suzuki Y, Takagi R
Environ Health Prev Med. 2011; 12(3):129-37.
PMID: 21432066
PMC: 2723229.
DOI: 10.1007/BF02898027.
The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.
Steinkellner T, Freissmuth M, Sitte H, Montgomery T
Biol Chem. 2011; 392(1-2):103-15.
PMID: 21194370
PMC: 4497800.
DOI: 10.1515/BC.2011.016.
The intriguing effects of ecstasy (MDMA) on cognitive function in mice subjected to a minimal traumatic brain injury (mTBI).
Edut S, Rubovitch V, Schreiber S, Pick C
Psychopharmacology (Berl). 2010; 214(4):877-89.
PMID: 21120456
DOI: 10.1007/s00213-010-2098-y.
Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine (MDMA) in striatum.
Scheidweiler K, Ladenheim B, Cadet J, Huestis M
Neurotox Res. 2009; 18(2):200-9.
PMID: 19851718
PMC: 2917895.
DOI: 10.1007/s12640-009-9124-z.
Effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats.
Galizio M, McKinney P, Cerutti D, Pitts R
Pharmacol Biochem Behav. 2009; 94(2):305-11.
PMID: 19772870
PMC: 2763969.
DOI: 10.1016/j.pbb.2009.09.010.
MDMA (Ecstasy) decreases the number of neurons and stem cells in embryonic cortical cultures.
Kindlundh-Hogberg A, Pickering C, Wicher G, Hober D, Schioth H, Fex Svenningsen A
Cell Mol Neurobiol. 2009; 30(1):13-21.
PMID: 19543826
PMC: 11498611.
DOI: 10.1007/s10571-009-9426-y.
Modulation of MDMA-induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice.
Belkai E, Scherrmann J, Noble F, Marie-Claire C
Addict Biol. 2009; 14(3):245-52.
PMID: 19523041
PMC: 2922624.
DOI: 10.1111/j.1369-1600.2009.00156.x.
What's in a label? Ecstasy sellers' perceptions of pill brands.
Duterte M, Jacinto C, Sales P, Murphy S
J Psychoactive Drugs. 2009; 41(1):27-37.
PMID: 19455907
PMC: 2717897.
DOI: 10.1080/02791072.2009.10400672.
Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.
Capela J, Carmo H, Remiao F, Bastos M, Meisel A, Carvalho F
Mol Neurobiol. 2009; 39(3):210-71.
PMID: 19373443
DOI: 10.1007/s12035-009-8064-1.
Neuroimaging in human MDMA (Ecstasy) users.
Cowan R, Roberts D, Joers J
Ann N Y Acad Sci. 2008; 1139:291-8.
PMID: 18991874
PMC: 2677829.
DOI: 10.1196/annals.1432.007.